Inclusion Criteria:  Diagnosis as prostate cancer and need ADT Decision made to prescribe FIRMAGON prior to enrollment Willingness and ability to provide written informed consent The patients are taking the marketed drug FIRMAGON  Exclusion Criteria:  Not signed informed consent Any patients who is unsuitable to participate in this study because of any other reasons will not be qualified to participate in this study.